Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q1 2023 vs. Q4 2022
How the institutions holding Biofrontera Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 14 | 16 | +2 |
| Shares | 795.6K | 849.3K | +53.8K (+6.8%) |
| Value | $729.4K | $517.9K | −$211.5K (−29.0%) |
New holders (4)
Institutions that held Biofrontera Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mesirow Financial Investment Management, Inc. | 17,808 | $10.9K | 0.05% |
| UBS Group AG | 1,212 | $739 | 0.00% |
| Royal Bank of Canada | 225 | $0 | 0.00% |
| VitalStone Financial, LLC | 304 | – | – |
Sold out (2)
Institutions that held Biofrontera Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Jane Street Group, LLC | 11,047 | $10.1K |
| Bank of America Corp | 36 | $32 |